Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, February 26, 2016
inviCRO, LLC, and Molecular NeuroImaging, LLC, both providers of imaging service solutions and analysis for research and drug development, announced they will merge all activities to provide the most comprehensive set of imaging services across the ...
read more
Wednesday, February 24, 2016
Deceleration of the pharmaceutical patent cliff, combined with expectations of a patent 'slope' for biologics, will support innovative drug manufacturers' U.S. sales, according to the first report in Fitch Ratings' 'Navigating the Pharmaceutical ...
read more
Wednesday, February 24, 2016
Aptuit and Icagen have announced a strategic alliance to give drug discovery customers access to ion channel and transporter technologies and expert services.
read more
Wednesday, February 24, 2016
Recipharm AB has entered into an agreement to acquire Italian CDMO, Mitim Srl adding scale and capabilities to the group. Mitim is currently owned by a private Italian family and is specialized in the filling of injectable beta lactam products. It ...
read more
Wednesday, February 24, 2016
Sanofi has announced that the license and development agreement between Sanofi and kaléo, formerly Intelliject Inc., the developer of Auvi-Q® (epinephrine injection, USP), will terminate later this year.
read more
Wednesday, February 24, 2016
Teva Pharmaceutical Industries is embarking on a strategic enterprise-wide corporate identity program to build a global brand.
read more
Wednesday, February 24, 2016
Albumedix has announced new data that supports an exclusive agreement with ThioLogics, a UCL Business (UCLB) company, to commercialize the next generation of stable albumin drug conjugates.
read more
Monday, February 22, 2016
BioAgilytix, a provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has announced the acquisition of IPM Biotech, a German-based bioanalytical contract research laboratory renowned for its expertise ...
read more
Monday, February 22, 2016
Patheon, a global provider of pharmaceutical development and manufacturing services has announced it has signed a strategic agreement with Grünenthal, an independent, family-owned, international research-based pharmaceutical group headquartered in ...
read more
Monday, February 22, 2016
Lannett Company has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray USP, 5 mg/spray and 20 mg/spray, the therapeutic equivalent to the reference listed drug...
read more
Thursday, February 18, 2016
AAIPharma Services Corp./Cambridge Major Laboratories a provider of custom manufacturing and development services for the pharmaceutical and biotechnology industries, has announced the planned investment of at least $10.7 Million to relocate its St. ...
read more
Thursday, February 18, 2016
PAREXEL International Corporation, a global biopharmaceutical services organization, today has announced expanded services and capabilities in genomic-based drug development.
read more
Thursday, February 18, 2016
CMC Biologics A/S and IDT Biologika GmbH have announced the formation of a strategic collaboration to provide a complete and efficient solution for the manufacture of antibody drug conjugates (ADCs).
read more
Wednesday, February 17, 2016
Aldevron, a provider of products and contract manufacturing services for the pharmaceutical and biotechnology industries, announces the appointment of Jenny Stafford as Vice President and General Manager. Ms. Stafford’s responsibilities include ...
read more
Wednesday, February 17, 2016
Asterand Bioscience has been awarded a five-year, $6.5M contract from the National Institutes of Health (NIH) to provide oncology specimens with associated clinical data to the Clinical Proteomic Tumor Analysis Consortium (CPTAC).
read more